144 related articles for article (PubMed ID: 36839948)
1. Role of HIKESHI on Hyperthermia for Castration-Resistant Prostate Cancer and Application of a Novel Magnetic Nanoparticle with Carbon Nanohorn for Magnetic Hyperthermia.
Nagai T; Kawai N; Gonda M; Iida K; Etani T; Kobayashi D; Naiki T; Naiki-Ito A; Ando R; Yamaguchi S; Sugahara Y; Ueno S; Tsutsumiuchi K; Imae T; Yasui T
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839948
[TBL] [Abstract][Full Text] [Related]
2. HIKESHI silencing can enhance mild hyperthermia sensitivity in human oral squamous cell carcinoma HSC‑3 cells.
Tabuchi Y; Maekawa K; Torigoe M; Furusawa Y; Hirano T; Minagawa S; Yunoki T; Hayashi A
Int J Mol Med; 2020 Jul; 46(1):58-66. PubMed ID: 32377716
[TBL] [Abstract][Full Text] [Related]
3. Heat shock-induced HIKESHI protects cell viability via nuclear translocation of heat shock protein 70.
Yanoma T; Ogata K; Yokobori T; Ide M; Mochiki E; Toyomasu Y; Yanai M; Kogure N; Kimura A; Suzuki M; Nakazawa N; Bai T; Oyama T; Asao T; Shirabe K; Kuwano H
Oncol Rep; 2017 Sep; 38(3):1500-1506. PubMed ID: 28731175
[TBL] [Abstract][Full Text] [Related]
4. Nuclear import carrier Hikeshi cooperates with HSP70 to promote murine oligodendrocyte differentiation and CNS myelination.
Li L; Li D; Sun D; Zhang X; Lei W; Wu M; Huang Q; Nian X; Dai W; Lu X; Zhou Z; Zhu Y; Xiao Y; Zhang L; Mo W; Liu Z; Zhang L
Dev Cell; 2023 Nov; 58(21):2275-2291.e6. PubMed ID: 37865085
[TBL] [Abstract][Full Text] [Related]
5. Iron oxide nanoparticle hyperthermia and chemotherapy cancer treatment.
Petryk A; Giustini A; Ryan P; Strawbridge R; Hoopes P
Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810N. PubMed ID: 25346581
[TBL] [Abstract][Full Text] [Related]
6. Hikeshi, a nuclear import carrier for Hsp70s, protects cells from heat shock-induced nuclear damage.
Kose S; Furuta M; Imamoto N
Cell; 2012 Apr; 149(3):578-89. PubMed ID: 22541429
[TBL] [Abstract][Full Text] [Related]
7. Lack of Hikeshi activates HSF1 activity under normal conditions and disturbs the heat-shock response.
Kose S; Imai K; Watanabe A; Nakai A; Suzuki Y; Imamoto N
Life Sci Alliance; 2022 Sep; 5(9):. PubMed ID: 35580988
[TBL] [Abstract][Full Text] [Related]
8. Hikeshi modulates the proteotoxic stress response in human cells: Implication for the importance of the nuclear function of HSP70s.
Rahman KMZ; Mamada H; Takagi M; Kose S; Imamoto N
Genes Cells; 2017 Nov; 22(11):968-976. PubMed ID: 28980748
[TBL] [Abstract][Full Text] [Related]
9. Heat-shock stress activates a novel nuclear import pathway mediated by Hikeshi.
Imamoto N; Kose S
Nucleus; 2012; 3(5):422-8. PubMed ID: 22895094
[TBL] [Abstract][Full Text] [Related]
10. Combination treatment with docetaxel and histone deacetylase inhibitors downregulates androgen receptor signaling in castration-resistant prostate cancer.
Park SE; Kim HG; Kim DE; Jung YJ; Kim Y; Jeong SY; Choi EK; Hwang JJ; Kim CS
Invest New Drugs; 2018 Apr; 36(2):195-205. PubMed ID: 29110173
[TBL] [Abstract][Full Text] [Related]
11. Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer.
Naiki-Ito A; Naiki T; Kato H; Iida K; Etani T; Nagayasu Y; Suzuki S; Yamashita Y; Inaguma S; Onishi M; Tanaka Y; Yasui T; Takahashi S
Carcinogenesis; 2020 Aug; 41(8):1145-1157. PubMed ID: 31805186
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional analysis of Hikeshi, a new nuclear transport receptor of Hsp70s.
Song J; Kose S; Watanabe A; Son SY; Choi S; Hong H; Yamashita E; Park IY; Imamoto N; Lee SJ
Acta Crystallogr D Biol Crystallogr; 2015 Mar; 71(Pt 3):473-83. PubMed ID: 25760597
[TBL] [Abstract][Full Text] [Related]
13. Leukoencephalopathy and early death associated with an Ashkenazi-Jewish founder mutation in the Hikeshi gene.
Edvardson S; Kose S; Jalas C; Fattal-Valevski A; Watanabe A; Ogawa Y; Mamada H; Fedick AM; Ben-Shachar S; Treff NR; Shaag A; Bale S; Gärtner J; Imamoto N; Elpeleg O
J Med Genet; 2016 Feb; 53(2):132-7. PubMed ID: 26545878
[TBL] [Abstract][Full Text] [Related]
14. Assessment of intratumor non-antibody directed iron oxide nanoparticle hyperthermia cancer therapy and antibody directed IONP uptake in murine and human cells.
Hoopes P; Tate J; Ogden J; Strawbridge R; Fiering S; Petryk A; Cassim S; Giustini A; Demidenko E; Ivkov R; Barry S; Chinn P; Foreman A
Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810P. PubMed ID: 25346583
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution of antibody-targeted and non-targeted iron oxide nanoparticles in a breast cancer mouse model.
Tate JA; Kett W; NDong C; Griswold KE; Hoopes PJ
Proc SPIE Int Soc Opt Eng; 2013 Feb; 8584():85840G. PubMed ID: 25301995
[TBL] [Abstract][Full Text] [Related]
16. Hollow Magnetic Nanocatalysts Drive Starvation-Chemodynamic-Hyperthermia Synergistic Therapy for Tumor.
Ying W; Zhang Y; Gao W; Cai X; Wang G; Wu X; Chen L; Meng Z; Zheng Y; Hu B; Lin X
ACS Nano; 2020 Aug; 14(8):9662-9674. PubMed ID: 32709200
[TBL] [Abstract][Full Text] [Related]
17. Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer.
Lamoureux F; Thomas C; Yin MJ; Fazli L; Zoubeidi A; Gleave ME
Eur Urol; 2014 Jul; 66(1):145-55. PubMed ID: 24411988
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer.
Nakayama H; Sekine Y; Oka D; Miyazawa Y; Arai S; Koike H; Matsui H; Shibata Y; Suzuki K
Prostate; 2022 Feb; 82(3):314-322. PubMed ID: 34843630
[TBL] [Abstract][Full Text] [Related]
19. NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer.
Chen Z; Jiang Q; Zhu P; Chen Y; Xie X; Du Z; Jiang L; Tang W
Prostate; 2019 Jan; 79(1):44-53. PubMed ID: 30178500
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with radiation and hyperthermia-induced clinical complete response of small cell carcinoma of prostate.
Kawai N; Nagai T; Naiki-Ito A; Iida K; Etani T; Naiki T; Hamamoto S; Okada A; Murai T; Yasui T
IJU Case Rep; 2022 Mar; 5(2):113-116. PubMed ID: 35252794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
